Is CoreWeave (CRWV) Fully Priced After Q2 Earnings And A $104 Billion Backlog?

CoreWeave

CoreWeave

CRWV

0.00

CoreWeave (CRWV) is back in focus after Q2 2026 results topped expectations, its contracted revenue backlog reached about $104 billion, and management raised capital spending plans for further AI cloud capacity buildout.

CoreWeave’s share price has been volatile, with a 7 day share price return of 16.09% and a 30 day share price return of 36.49% around the Q2 earnings. The 1 year total shareholder return of 5.29% shows more muted longer term progress.

If CoreWeave’s AI cloud story has your attention, this can be a moment to scan the broader opportunity set and see which other AI infrastructure stocks are moving through 55 AI infrastructure stocks.

For CoreWeave, a 36% move in a month sits on top of heavy losses, rapid capacity buildout and a huge contracted backlog. Is this swing mainly about changing sentiment, or about what you are actually paying for?

Most Popular Narrative: 50% Overvalued

The most followed CoreWeave narrative currently anchors on a fair value of $70 per share compared with the last close at $105.26. That gap creates a clear valuation tension for anyone looking at the recent price swing.

When comparing the risk-reward profile to peers like NBIS, CRWV’s extreme reliance on debt-fueled growth makes it a high-beta play on the AI cycle. Given the tightening margins in the GPU-rental space, there is a significant asymmetric risk to the downside. The market may eventually re-rate these "borrow-to-buy" models from high-growth tech multiples to lower-tier financing-company multiples.

Read the complete narrative. Read the complete narrative.

This narrative leans heavily on aggressive revenue growth assumptions, a modest profit margin profile and a specific valuation multiple applied to those future earnings. Want to see which combination of growth, profitability and discount rate supports a fair value that sits well below CoreWeave’s current $105.26 share price? The full narrative lays out the exact numbers behind that $70 target.

Result: Fair Value of $70 (OVERVALUED)

However, CoreWeave could surprise skeptics if contracted revenue converts as planned, and if capital spending translates into stronger profitability and clearer visibility on future cash generation.

Another View: What CoreWeave’s Sales Multiple Is Saying

The community narrative around CoreWeave points to a fair value of $70, which implies the stock trades rich. Yet on a simple P/S basis of 7.6x, CoreWeave is cheaper than its peer average of 11.1x and far below a fair ratio of 27.2x that the market could move towards. Is this a value cushion or a signal that peers are priced too high?

Our comparison-based view raises a different set of questions than the narrative’s $70 target, and it leaves you weighing whether CoreWeave’s risks justify such a wide gap to both peers and the fair ratio. See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:CRWV P/S Ratio as at Aug 2026
NasdaqGS:CRWV P/S Ratio as at Aug 2026

Next Steps

With CoreWeave sparking strong views on both risk and reward, this is a good moment to move quickly, check the details, and form your own stance. To weigh both sides in one place, start by reviewing the 1 key reward and 4 important warning signs

Looking for more investment ideas beyond CoreWeave?

If CoreWeave has sharpened your focus on opportunities, do not stop here. The Simply Wall Street Screener can surface other stocks that fit your style and risk comfort.

  • Target reliable cash generation and solid fundamentals by reviewing companies highlighted in the solid balance sheet and fundamentals stocks screener (50 results).
  • Hunt for potential mispriced opportunities by checking stocks featured in the 50 high quality undervalued stocks.
  • Aim for steady income potential by scanning companies included in the 10 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.